Company: CI
Filing Date: 2025-07-31
Form Type: 10-Q
Source: 0001739940-25-000028
Chunk: 5

Company: Cigna Group
Filing Date: 2025-07-31
Form: 10-Q
Item: Part II, Item 4
Chunk 5
---
 Company's senior unsecured credit ratings.The Credit Agreement also contains customary covenants and restrictions, including a financial covenant that the Company's leverage ratio, as defined in the Credit Agreement, may not exceed 60%, subject to certain exceptions upon the consummation of an acquisition.

Commercial Paper. Under our commercial paper program, we may issue short-term, unsecured commercial paper notes privately placed on a discounted basis through certain broker-dealers at any time not to exceed an aggregate amount of $6.5 billion. Amounts available under the program may be borrowed, repaid and re-borrowed from time to time. The net proceeds of issuances have been and are expected to be used for general corporate purposes. The commercial paper program had approximately $1.2 billion outstanding as of June 30, 2025 and an average interest rate of 4.51%. 

Debt Covenants. The Company was in compliance with its debt covenants as of June 30, 2025.

Interest ExpenseInterest expense on long-term and short-term debt was $338 million for the three months ended and $700 million for the six months ended June 30, 2025, compared with $378 million for the three months ended and $747 million for the six months ended June 30, 2024.

13

Note 8 – Common and Preferred Stock

DividendsThe following table provides details of the Company's dividend payments:Record DatePayment DateAmount per ShareTotal Amount Paid (in millions)2025March 5, 2025March 20, 2025$1.51$412June 3, 2025June 18, 2025$1.51$4012024March 6, 2024March 21, 2024$1.40$401June 4, 2024June 20, 2024$1.40$392On July 22, 2025, the Board of Directors declared the third quarter cash dividend of $1.51 per share of The Cigna Group common stock to be paid on September 18, 2025 to shareholders of record on September 4, 2025. The Company currently intends to pay regular quarterly dividends, with future declarations subject to approval by its Board of Directors and the Board of Director's determination that the declaration of dividends remains in the best interests of The Cigna Group and its shareholders. The decision of whether to pay future dividends and the amount of any such